We are live on
!
Find out more
AbbVie
ABBV
ABBV
4,071 hedge funds and large institutions have $285B invested in AbbVie in 2026 Q1 according to their latest regulatory filings, with 189 funds opening new positions, 1,717 increasing their positions, 1,703 reducing their positions, and 180 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
5% less capital invested
Capital invested by funds: $301B → $285B (-$16.1B)
11% less call options, than puts
Call options by funds: $2.21B | Put options by funds: $2.5B
12% less funds holding in top 10
Funds holding in top 10: 198 → 174 (-24)
Holders
4,071
Holding in Top 10
174
Calls
$2.21B
Puts
$2.5B
Top Buyers
| 1 | +$1.88B | |
| 2 | +$1.3B | |
| 3 | +$965M | |
| 4 |
DAM
Diamant Asset Management
Ridgefield,
Connecticut
|
+$811M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$782M |
Top Sellers
| 1 | -$2.71B | |
| 2 | -$1.78B | |
| 3 | -$1.74B | |
| 4 |
Corient Private Wealth
Miami,
Florida
|
-$596M |
| 5 |
Morgan Stanley
New York
|
-$449M |
